Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
Bank Profitability Declining in Europe: Morilla-Giner
43:25 - Banks' profitability is declining in Europe as Tier 1 capital is built up and they become safer institutions, according to Pau Morilla-Giner, chief investment officer of London & Capital Group Ltd. He spoke in an interview with Jonathan Ferro on Bloomberg Television's "On the Move." Bloomberg's Julia Verlaine also took part in the discussion. (Source: Bloomberg)
  • We're Trying to Avoid Destroying the Planet: McGann
  • U.K. Housing Is Performing Quite Strongly: Redfern
  • Consumers Are Willing to Spend on Great Content: Sky CFO